These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 4763139)

  • 61. Delta-aminolevulinic acid dehydratase activity in erythrocytes for the evaluation of lead poisoning.
    Nakao K; Wada O; Yano Y
    Clin Chim Acta; 1968 Feb; 19(2):319-25. PubMed ID: 5645501
    [No Abstract]   [Full Text] [Related]  

  • 62. Failure of the urinary delta-aminolevulinic acid test to detect pediatric lead poisoning.
    Blanksma LA; Sachs HK; Murray EF; O'Connell MJ
    Am J Clin Pathol; 1970 Jun; 53(6):956-62. PubMed ID: 5515391
    [No Abstract]   [Full Text] [Related]  

  • 63. The use of the urinary excretion of delta-aminolevulinic acid as a criterion for lead absorption in industrial medicine and insurance medicine.
    Lahaye D; Roosels D; Bossiroy JM; van Assche F
    Int Arch Occup Environ Health; 1977 Aug; 39(3):191-8. PubMed ID: 924689
    [No Abstract]   [Full Text] [Related]  

  • 64. [Lead exposure of selected population groups. II. The lead level of the blood and delta-aminolevulinic acid level of the urine in the workers in a modern lead and zinc plant].
    Grabecki J; Jarkowski M; Michalewicz L
    Rocz Panstw Zakl Hig; 1981; 32(5-6):439-47. PubMed ID: 7344057
    [No Abstract]   [Full Text] [Related]  

  • 65. [Renal delta-aminolevulinic acid excretion in persons not exposed to lead].
    Massmann W
    Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie; 1982 Jun; 32(6):210-2. PubMed ID: 7113496
    [No Abstract]   [Full Text] [Related]  

  • 66. A chronobiological study of delta-amino levulinic acid urinary excretion.
    Botta A; Bruguerolle B; Bartolin R; Bouvenot G
    Chronobiol Int; 1987; 4(4):509-12. PubMed ID: 3435928
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A single column method for the determination of urinary delta-aminolevulinic acid.
    Sun MW; Stein E; Gruen FW
    Clin Chem; 1969 Mar; 15(3):183-9. PubMed ID: 5773268
    [No Abstract]   [Full Text] [Related]  

  • 68. [Studies on subjects exposed to lead in working sites with primary low lead concentration].
    Beckert J; Bühlmeyer G; Unckell F; Tech G
    Zentralbl Arbeitsmed; 1971 Jul; 21(7):207-13. PubMed ID: 5563617
    [No Abstract]   [Full Text] [Related]  

  • 69. Quantitative determination of urinary delta-aminolevulinic acid as an index of lead exposure by high-performance liquid chromatography.
    Ogata M; Taguchi T
    Ind Health; 1986; 24(4):259-64. PubMed ID: 3818368
    [No Abstract]   [Full Text] [Related]  

  • 70. The urinary excretion of 5-hydroxyindoleacetic acid in industrial lead exposure.
    Urbanowicz H; Grabecki J; Kozielska J
    Med Lav; 1969 Oct; 60(10):582-6. PubMed ID: 5380048
    [No Abstract]   [Full Text] [Related]  

  • 71. [Adjustment of urinary delta-aminolevulinic acid concentrations in workers exposed to lead and heat. Adjustments of specific gravity to 1.020 and urinary volume coefficients].
    Hirano H; Ohmichi M; Hanazawa K; Ishikawa K; Hirashima N; Usui S; Yoshio K
    Sangyo Igaku; 1984 May; 26(3):205-11. PubMed ID: 6521057
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tests for prevention of chronic inorganic lead poisoning in industry.
    Bardodej Z; Hoschek R
    Med Lav; 1971; 62(6):344-50. PubMed ID: 5163018
    [No Abstract]   [Full Text] [Related]  

  • 73. [Lead and delta-aminolevulinic acid in urine: quality control].
    Grisler R; Gobbi A; Colombo G; Colombo R; Valla C
    Med Lav; 1974; 65(5-6):202-5. PubMed ID: 4456167
    [No Abstract]   [Full Text] [Related]  

  • 74. [Re-assessment of indicators for screening lead poisoning].
    Lü L; Lin G; Xu M; Zou H; Wang Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):275-8. PubMed ID: 11864490
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Chromosome damage after occupational exposure to lead].
    Schwanitz G; Lehnert G; Gebhart E
    Dtsch Med Wochenschr; 1970 Aug; 95(32):1636-41. PubMed ID: 5433400
    [No Abstract]   [Full Text] [Related]  

  • 76. The measurement of urinary delta-aminolevulinic acid in detection of childhood lead poisoning.
    Vincent WF; Ullmann WW; Weidner GL
    Am J Clin Pathol; 1970 Jun; 53(6):963-4. PubMed ID: 5509832
    [No Abstract]   [Full Text] [Related]  

  • 77. [The problem of lead exposure caused by the exhaust gases of motor vehicles. A contribution to the applicability of the determination of delta-aminolaevulinic acid in urine as a criterion for the lead exposure caused by environmental factors].
    Schubert HW; Sangl H
    Zentralbl Bakteriol Orig B; 1972 Jun; 155(5):470-5. PubMed ID: 4124477
    [No Abstract]   [Full Text] [Related]  

  • 78. Delta-amino-levulinic acid as an early sign of lead exposure.
    Djuric D; Novak L; Milic S; Kalic-Filipovic D
    Med Lav; 1966 Mar; 57(3):161-6. PubMed ID: 5985035
    [No Abstract]   [Full Text] [Related]  

  • 79. [Porphyrin metabolism in endemic nephropathy and in persons in danger of lead poisoning].
    Iwanow ED
    Munch Med Wochenschr; 1968 Aug; 110(31):1783-9. PubMed ID: 5755403
    [No Abstract]   [Full Text] [Related]  

  • 80. Simple method for determination of urinary -aminolevulinic acid as an index of lead exposure.
    Tomokuni K; Ogata M
    Clin Chem; 1972 Dec; 18(12):1534-8. PubMed ID: 4639865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.